Canada markets closed

Ocuphire Pharma, Inc. (OCUP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9900+0.1400 (+7.57%)
At close: 04:00PM EDT
1.9400 -0.05 (-2.51%)
After hours: 07:17PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 49.38M
Enterprise Value 30.21M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.26
Price/Book (mrq)0.99
Enterprise Value/Revenue 1.59
Enterprise Value/EBITDA -3.03

Trading Information

Stock Price History

Beta (5Y Monthly) 0.24
52-Week Change 3-68.16%
S&P500 52-Week Change 322.38%
52 Week High 36.6000
52 Week Low 31.5000
50-Day Moving Average 31.9980
200-Day Moving Average 32.9558

Share Statistics

Avg Vol (3 month) 3228.58k
Avg Vol (10 day) 3189.69k
Shares Outstanding 524.81M
Implied Shares Outstanding 624.81M
Float 823.83M
% Held by Insiders 16.51%
% Held by Institutions 113.39%
Shares Short (Apr 15, 2024) 41.58M
Short Ratio (Apr 15, 2024) 45.74
Short % of Float (Apr 15, 2024) 46.56%
Short % of Shares Outstanding (Apr 15, 2024) 46.37%
Shares Short (prior month Mar 15, 2024) 41.65M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 06, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Nov 06, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -52.42%
Operating Margin (ttm)-321.05%

Management Effectiveness

Return on Assets (ttm)-12.83%
Return on Equity (ttm)-20.77%

Income Statement

Revenue (ttm)19.05M
Revenue Per Share (ttm)0.88
Quarterly Revenue Growth (yoy)-95.80%
Gross Profit (ttm)N/A
EBITDA -10.56M
Net Income Avi to Common (ttm)-9.99M
Diluted EPS (ttm)-0.4600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)50.52M
Total Cash Per Share (mrq)2.04
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)13.35
Book Value Per Share (mrq)2.08

Cash Flow Statement

Operating Cash Flow (ttm)-1.11M
Levered Free Cash Flow (ttm)244.12k